Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis

被引：0

作者：

Spencer, Andrew ^{[1
]}

Mollee, Peter ^{[2
]}

Blacklock, Hilary Anne ^{[3
]}

Harrison, Simon ^{[4
,5
]}

Quach, Hang ^{[6
]}

Ho, P. Joy ^{[7
]}

Spearing, Ruth

Hocking, Jay ^{[8
]}

Augustson, Bradley ^{[9
]}

Prince, H. Miles ^{[10
]}

Moore, Elizabeth M. ^{[11
]}

McQuilten, Zoe

Wood, Erica M. ^{[11
]}

Wellard, Cameron

机构：

[1] Monash Univ, Alfred Hlth, Dept Clin Haematol, Melbourne, Vic, Australia

[2] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld, Australia

[3] Middlemore Hosp, Auckland, New Zealand

[4] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia

[5] Royal Melbourne Hosp, Melbourne, Vic, Australia

[6] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia

[7] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia

[8] Box Hill Hosp, Dept Haematol, Melbourne, Vic, Australia

[9] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia

[10] Epworth Freemasons Hosp, Melbourne, Vic, Australia

[11] Monash Univ, Transfus Res Unit, Melbourne, Vic, Australia

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129431

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

269

引用

页数：4

共 50 条

[21] Ixazomib Based Maintenance Therapy for the Patients with Newly Diagnosed Multiple Myeloma in Real-World Practice
Zhong, Liye
Wei, Yongqiang
Ping, Baohong
Li, Xin
Peng, Hongling
Li, Yongqain
Tian, Yuyang
Liu, Zelin
Luo, Jun
Su, Yongzhong
Chen, Haifei
He, Yanjuan
Li, Hongliang
Wu, Congming
Sun, Zhiqiang
Shi, Keqian
Li, Xiaoliang
Zhang, Qing
Hu, Guoyu
Huang, Gang
Huang, Zhenqian
Wang, Weida
Xia, Zhongjun
BLOOD, 2021, 138
[22] Bortezomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma patients: a real-world study of China
Xu, Jingyu
Yan, Wenqiang
Fan, Huishou
Liu, Jiahui
Du, Chenxing
Deng, Shuhui
Sui, Weiwei
Xu, Yan
Qiu, Lugui
An, Gang
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S159 - S159
[23] Real-World Outcomes of High-Risk Multiple Myeloma: Retrospective Analysis of Cams&pumc
Sui, Weiwei
Deng Shuhui
An Gang
Yan Xu
Yi, Shuhua
Zou Dehui
Qiu, Lugui, Sr.
BLOOD, 2018, 132
[24] Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis
Poveda-Garcia, Andrea
Ruiz, Estela
Moreno, Maria Jose
Espanol, Ignacio
Sanchez-Salinas, Andres
Garcia-Hernandez, Ana Maria
Blanquer, Miguel
Martinez, Inmaculada
Sanchez-Villalobos, Maria
Garay, Maria Carmen Garcia
Salido, Eduardo
Heredia, Angela
Navarro-Almenzar, Begona
Monserrat, Jorge
Sanchez-Salas, Jose Antonio
Martinez-Mellado, Antonio Jose
Minguela, Alfredo
Campillo, Jose Antonio
Lopez-Hernandez, Ruth
Galian, Jose Antonio
Moraleda, Jose M.
Roldan, Vanessa
Cabanas, Valentin
BONE MARROW TRANSPLANTATION, 2024, 59 (11) : 1625 - 1627
[25] Survival in Patients with Newly Diagnosed Myeloma Undergoing Therapy with Lenalidomide and Dexamethasone: Impact of High-Risk Cytogenetic Risk Status on Outcome
Kapoor, Prasnant
Kumar, Shaji
Fonseca, Rafael
Lacy, Martha Q.
Wilzig, Thomas E.
Hayman, Suzanne R.
Dispenzieri, Angela
Buadi, Francis
Bergsagel, P. Leif
Gertz, Morie
Dalton, Robert
Mikhael, Joseph
Dingli, David
Reeder, Craig B.
Lust, John A.
Russell, Stephen
Roy, Vivek
Zeldenrust, Steven R.
Stewart, Keith
Kyle, Robert A.
Greipp, Philip R.
Rajkumar, S. Vincent
BLOOD, 2008, 112 (11) : 42 - 43
[26] Real World Outcomes of Newly Diagnosed High-Risk Multiple Myeloma Patients Treated at Princess Margaret Cancer Centre: A Retrospective Chart Review
Reece, Donna
Mikhaeil, John
Masih-Khan, Esther
Atenafu, Eshetu G.
Chen, Christine I.
Kukreti, Vishal
Prica, Anca
Tiedemann, Rodger
Trudel, Suzanne
BLOOD, 2017, 130
[27] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
María José Cejalvo
Gabriela Bustamante
Esther González
Judith Vázquez-Álvarez
Ricarda García
Ángel Ramírez-Payer
Ernesto Pérez-Persona
Eugenia Abella
Sebastián Garzón
Antoni García
Isidro Jarque
Marta Sonia González
Antonia Sampol
Cristina Motlló
Josep María Martí
Magdalena Alcalá
Rafael Duro
Yolanda González
José Luis Sastre
Josep Sarrà
Giselle Lostaunau
Rocío López
Javier de la Rubia
Annals of Hematology, 2021, 100 : 1769 - 1778
[28] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
Cejalvo, Maria Jose
Bustamante, Gabriela
Gonzalez, Esther
Vazquez-Alvarez, Judith
Garcia, Ricarda
Ramirez-Payer, Angel
Perez-Persona, Ernesto
Abella, Eugenia
Garzon, Sebastian
Garcia, Antoni
Jarque, Isidro
Gonzalez, Marta Sonia
Sampol, Antonia
Motllo, Cristina
Marti, Josep Maria
Alcala, Magdalena
Duro, Rafael
Gonzalez, Yolanda
Sastre, Jose Luis
Sarra, Josep
Lostaunau, Giselle
Lopez, Rocio
de la Rubia, Javier
ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1769 - 1778
[29] Real-world economic outcomes of early progression in newly diagnosed multiple myeloma (NDMM) patients (Pts).
Clancy, Zoe
Pandya, Shivani
Shrestha, Sulena
Wang, Li
Baser, Onur
Ni, Quanhong
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
[30] Real-world outcomes (RWO) with tandem transplantation in patients (pts) with newly diagnosed multiple myeloma (NDMM)
Parmar, Harsh
Barcellos, Anna
Biran, Noa
Phull, Pooja
Vesole, David H.
Belli, Andrew J.
Fernandes, Laura L.
Hansen, Eric
Zettler, Christina
Wang, Ching-Kun
Goran, Stefanie
Anderson, Courtney
Doucette, Kimberley
Gunning, Thomas S.
Ip, Andrew
Siegel, David Samuel DiCapua
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →